Study on biomarkers of Qi and Yin deficiency syndrome in chronic heart failure based on proteomics

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033155

Enrollment

Unknown

Registered

2020-05-22

Start date

2020-06-01

Completion date

Unknown

Last updated

2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure

Interventions

Qi and Yin deficiency syndrome group:N/A

non Qi and Yin deficiency syndrome group:N/A

Healthy control group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the western medicine diagnosis standard of chronic heart failure; 2. Patients who meet the TCM diagnostic standard of Heart Qi Yin deficiency syndrome of chronic heart failure; 3. Patients willing to sign informed consent; 4. Patients with chronic heart failure younger than 85 years old; 5. The basic disease of heart failure is caused by cardiovascular diseases such as hypertension, coronary heart disease, cardiomyopathy, etc..

Exclusion criteria

Exclusion criteria: 1. Patients who refuse to accept this study or participate in other studies in the past 1 month; 2. Patients with severe liver, kidney, hematopoietic system diseases and malignant tumors have poor compliance; 3. Patients with acute coronary syndrome, pulmonary embolism and acute cerebrovascular disease; 4. Organ transplant patients; 5. Patients with terminal stage cachexia.

Design outcomes

Primary

Measure	Time frame
Proteomics;	—

Countries

China

Contacts

Public ContactZhixi Hu

Hu'nan Academy of Traditional Chinese Medicine Affiliated Hospital

zhixihu@qq.com+86 13574812411

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026